These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 32445489)

  • 21. Liver injury associated with the severity of COVID-19: A meta-analysis.
    Yang R; Feng J; Wan H; Zeng X; Ji P; Zhang J
    Front Public Health; 2023; 11():1003352. PubMed ID: 36817905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of coronavirus disease 2019 (COVID-19) on liver injury in China: A systematic review and meta-analysis.
    Zhao X; Lei Z; Gao F; Xie Q; Jang K; Gong J
    Medicine (Baltimore); 2021 Jan; 100(4):e24369. PubMed ID: 33530232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of L-carnitine on liver enzymes and biochemical factors in hepatic encephalopathy: A systematic review and meta-analysis.
    Abbasnezhad A; Choghakhori R; Kashkooli S; Alipour M; Asbaghi O; Mohammadi R
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2062-2070. PubMed ID: 31254469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver injury predicts overall mortality in severe COVID-19: a prospective multicenter study in Brazil.
    Pozzobon FM; Perazzo H; Bozza FA; Rodrigues RS; de Mello Perez R; Chindamo MC
    Hepatol Int; 2021 Apr; 15(2):493-501. PubMed ID: 33534084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of liver injury in patients with coronavirus disease 2019 (COVID-19) : a systematic review and meta-analysis.
    Merola E; Pravadelli C; de Pretis G
    Acta Gastroenterol Belg; 2020; 83(3):454-460. PubMed ID: 33094594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver injury in patients with severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysis.
    Labenz C; Toenges G; Wörns MA; Sprinzl MF; Galle PR; Schattenberg JM
    Eur J Gastroenterol Hepatol; 2021 Sep; 33(9):1194-1200. PubMed ID: 32796355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver injury in COVID-19: What do we know now?
    Yang HY; Jin B; Mao YL
    Hepatobiliary Pancreat Dis Int; 2020 Oct; 19(5):407-408. PubMed ID: 32753332
    [No Abstract]   [Full Text] [Related]  

  • 28. Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China.
    Lei F; Liu YM; Zhou F; Qin JJ; Zhang P; Zhu L; Zhang XJ; Cai J; Lin L; Ouyang S; Wang X; Yang C; Cheng X; Liu W; Li H; Xie J; Wu B; Luo H; Xiao F; Chen J; Tao L; Cheng G; She ZG; Zhou J; Wang H; Lin J; Luo P; Fu S; Zhou J; Ye P; Xiao B; Mao W; Liu L; Yan Y; Liu L; Chen G; Li H; Huang X; Zhang BH; Yuan Y
    Hepatology; 2020 Aug; 72(2):389-398. PubMed ID: 32359177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrointestinal and hepatic abnormalities in patients with confirmed COVID-19: A systematic review and meta-analysis.
    Zarifian A; Zamiri Bidary M; Arekhi S; Rafiee M; Gholamalizadeh H; Amiriani A; Ghaderi MS; Khadem-Rezaiyan M; Amini M; Ganji A
    J Med Virol; 2021 Jan; 93(1):336-350. PubMed ID: 32681674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effect of Saffron Consumption on Liver Function: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.
    Karimi E; Farrokhzad A; Darand M; Arab A
    Complement Med Res; 2021; 28(5):453-462. PubMed ID: 33735877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials.
    Jalali M; Rahimlou M; Mahmoodi M; Moosavian SP; Symonds ME; Jalali R; Zare M; Imanieh MH; Stasi C
    Pharmacol Res; 2020 Sep; 159():104799. PubMed ID: 32278041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The liver in COVID-19: prevalence, patterns, predictors, and impact on outcomes of liver test abnormalities.
    Goel H; Harmouch F; Garg K; Saraiya P; Daly T; Kumar A; Hippen JT
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e274-e281. PubMed ID: 33369962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses.
    Raoul JL; Bruix J; Greten TF; Sherman M; Mazzaferro V; Hilgard P; Scherubl H; Scheulen ME; Germanidis G; Dominguez S; Ricci S; Nadel A; Moscovici M; Voliotis D; Llovet JM
    J Hepatol; 2012 May; 56(5):1080-1088. PubMed ID: 22245896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrointestinal and hepatic manifestations of Corona Virus Disease-19 and their relationship to severe clinical course: A systematic review and meta-analysis.
    Kumar A; Arora A; Sharma P; Anikhindi SA; Bansal N; Singla V; Khare S; Srivastava A
    Indian J Gastroenterol; 2020 Jun; 39(3):268-284. PubMed ID: 32749643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal Liver Blood Tests in Patients with Hyperthyroidism: Systematic Review and Meta-Analysis.
    Scappaticcio L; Longo M; Maiorino MI; Pernice V; Caruso P; Esposito K; Bellastella G
    Thyroid; 2021 Jun; 31(6):884-894. PubMed ID: 33327837
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatic Injury in Patients With COVID-19.
    Kullar R; Patel AP; Saab S
    J Clin Gastroenterol; 2020; 54(10):841-849. PubMed ID: 32976196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 and the liver: the chicken or the egg dilemma.
    Ampuero J; Romero Gómez M
    Rev Esp Enferm Dig; 2021 Jul; 113(7):555. PubMed ID: 33569963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia.
    Li J; He X; Yuan Yuan ; Zhang W; Li X; Zhang Y; Li S; Guan C; Gao Z; Dong G
    Am J Infect Control; 2021 Jan; 49(1):82-89. PubMed ID: 32540370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholesterol and Triglyceride Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.
    Zinellu A; Paliogiannis P; Fois AG; Solidoro P; Carru C; Mangoni AA
    Front Public Health; 2021; 9():705916. PubMed ID: 34490188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients.
    Krishnan A; Prichett L; Tao X; Alqahtani SA; Hamilton JP; Mezey E; Strauss AT; Kim A; Potter JJ; Chen PH; Woreta TA
    World J Gastroenterol; 2022 Feb; 28(5):570-587. PubMed ID: 35316959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.